RANBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, we proved that RanBP3 was important in regulating proliferation and apoptosis in CML, and the potential mechanism was changing the distribution of cancer-related proteins between the cytoplasm and nucleus (Figure 6H).